The sympathetic nervous system in chronic heart failure

Lake, 1976, Use of plasma norepinephrine for evaluation of sympathetic neural function in man, Life Sci, 18, 1315, 10.1016/0024-3205(76)90210-1 Francis, 1990, Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the Studies of Left Ventricular Dysfunction (SOLVD), Circulation, 82, 1724, 10.1161/01.CIR.82.5.1724 Remme, 1994, Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans, J Am Coll Cardiol, 23, 82, 10.1016/0735-1097(94)90505-3 Swedberg, 1990, Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality, Circulation, 82, 1730, 10.1161/01.CIR.82.5.1730 Creager, 1982, Determinants of clinical response and survival in patients with congestive heart failure treated with captopril, Am Heart J, 104, 1147, 10.1016/0002-8703(82)90043-6 Cohn, 1984, Plasma norepinephrine is a guide to prognosis in patients with chronic heart failure, N Engl J Med, 311, 819, 10.1056/NEJM198409273111303 Packer, 1987, Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure, Circulation, 75, 80 Haskings, 1986, Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity, Circulation, 73, 615, 10.1161/01.CIR.73.4.615 Meredith, 1993, Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake, Circulation, 88, 136, 10.1161/01.CIR.88.1.136 Rundquist, 1997, Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure, Circulation, 95, 169, 10.1161/01.CIR.95.1.169 Imamura, 1996, Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload, J Am Coll Cardiol, 28, 371, 10.1016/0735-1097(96)00165-9 Viquerat, 1985, Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities, Am J Med, 78, 455, 10.1016/0002-9343(85)90338-9 Hirsh, 1987, Baroreceptor function in congestive heart failure: Effect on neurohormonal activation and regional vascular resistance, Circulation, 75, 36 Katz, 1990, Interplay between inotropic and lusitropic effects of cyclic adenosine monophosphate on the myocardial cell, Circulation, 82, 7 Walsh, 1990, Sympathetic control of diastolic function in congestive heart failure, Circulation, 82, 152 Starksen, 1986, Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression, 83, 8348 Rona, 1959, An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat, Arch Pathol, 67, 443 Cruickshank, 1987, Reduction of stress/catecholamine induced cardiac necrosis by beta-1 selective blockade, Lancet, 2, 585, 10.1016/S0140-6736(87)92984-9 Fleckenstein, 1973, Ca++ overload as the determinant factor in the production of catecholamine-induced myocardial lesions, Recent Adv Stud Cardiac Struct Metab, 2, 455 Mann, 1992, Adrenergic effects on the biology of the adult mammalian cardiocyte, Circulation, 85, 790, 10.1161/01.CIR.85.2.790 Chidsey, 1963, Myocardial norepinephrine concentration in man: Effects of reserpine and of congestive heart failure, N Engl J Med, 269, 653, 10.1056/NEJM196309262691302 Merson, 1963, On mediator exchange in compensatory hyperfunction and hypertrophy of the heart, Patol Fiziol Eksp Ter, 1, 32 Pool, 1967, Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure, Circ Res, 20, 349, 10.1161/01.RES.20.3.349 Spann, 1965, Mechanism of norepinephrine depletion in experimental heart failure produced by aortic constriction in the guinea pig, Circ Res, 17, 312, 10.1161/01.RES.17.4.312 Sole, 1975, Norepinephrine turnover in the heart and spleen of the cardiomyopathic Syrian hamster, Circ Res, 27, 855, 10.1161/01.RES.37.6.855 Eisenhofer, 1996, Cardiac sympathetic nerve function in congestive heart failure, Circulation, 93, 1667, 10.1161/01.CIR.93.9.1667 Abraham, 1997, Mechanism of increased cardiac adrenergic activity in heart failure: Evidence for decreased cardiac neuronal norepinephrine reuptake, Circulation, 96, 92 Daly, 1990, Myocardial catecholamines and the pathophysiology of heart failure, Circulation, 82, 35 Snider, 1973, The occurrence and functional significance of dopamine in some peripheral adrenergic nerves of the rat, Naunyn Schmiedebergs Arch Pharmacol, 278, 1, 10.1007/BF00501858 Sole, 1977, A possible change in the rate limiting step for cardiac norepinephrine synthesis in the cardiomyopathic Syrian hamster, Circ Res, 41, 814, 10.1161/01.RES.41.6.814 Sole, 1982, Increased dopamine in the failing hamster heart: Transvesicular transport of dopamine limits the rate of norepinephrine synthesis, Am J Cardiol, 49, 1682, 10.1016/0002-9149(82)90246-6 Vogel, 1969, Distribution of norepinephrine in the failing bovine heart: Correlation of chemical analysis and fluorescence microscopy, Circ Res, 24, 71, 10.1161/01.RES.24.1.71 Brutsaert, 1987, Nonuniformity: A physiologic modulator of contraction and relaxation of the normal heart, J Am Coll Cardiol, 9, 341, 10.1016/S0735-1097(87)80387-X Gelbland, 1973, Depressed transmembrane action potentials during experimentally induced ventricular failure in cats, Circ Res, 32, 625, 10.1161/01.RES.32.5.625 Fein, 1984, Combined renovascular hypertension and diabetes in rats: A new preparation of congestive cardiomyopathy, Circulation, 70, 318, 10.1161/01.CIR.70.2.318 Wit, 1977, Triggered and autonomic activity in the canine coronary sinus, Circ Res, 41, 433, 10.1161/01.RES.41.4.434 Packer, 1990, Role of the sympathetic nervous system in chronic heart failure: A historical perspective, Circulation, 82, 1 Bristow, 1988, Myocardial alpha and beta adrenergic receptors in heart failure: Is cardiac-derived norepinephrine the regulatory signal?, Eur Heart J, 9, 35, 10.1093/eurheartj/9.suppl_H.35 Bristow, 1988, alpha-1 Adrenergic receptors in the nonfailing and failing human heart, J Pharmacol Exp Ther, 247, 1039 Bristow, 1986, Beta-1 and beta-2 adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: Coupling of both receptor subtypes to muscle contraction and selective beta-1 receptor downregulation in heart failure, Circ Res, 59, 297, 10.1161/01.RES.59.3.297 Huang, 1993, The M(r) 35,000 beta-adrenergic receptor mRNA-binding protein induced by beta agonists requires both an AUUUA pentamer and U-rich domains for RNA recognition, J Biol Chem, 268, 25769, 10.1016/S0021-9258(19)74456-1 Port, 1992, Beta adrenergic agonists that downregulate receptor mRNA upregulate a M(r) 35,000 protein(s) that selectively binds to beta-adrenergic receptor mRNAs, J Biol Chem, 267, 24103, 10.1016/S0021-9258(18)35952-0 Pende, 1996, Regulation of the mRNA-binding protein AUF1 by activation of the beta-adrenergic receptor signal transduction pathway, J Biol Chem, 271, 8493, 10.1074/jbc.271.14.8493 Bristow, 1989, Beta-1 and beta-2 adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium, Mol Pharmacol, 35, 295 Bristow, 1991, Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy, Circulation, 84, 1024, 10.1161/01.CIR.84.3.1024 Ungerer, 1993, Altered expression of beta-adrenergic receptor kinase and beta-1 adrenergic receptors in the failing human heart, Circulation, 87, 454, 10.1161/01.CIR.87.2.454 Freedman, 1995, Phosphorylation and desensitization of the human beta-1 adrenergic receptor, J Biol Chem, 270, 17953, 10.1074/jbc.270.30.17953 Roth, 1991, Comparative rates of desensitization of beta-adrenergic receptors by the beta-adrenergic receptor kinase and the cyclic AMP dependent protein kinase, 88, 6201 Feldman, 1988, Increase of the Mr 40,000 pertussis toxin substrate (G protein) in the failing human heart, J Clin Invest, 82, 189, 10.1172/JCI113569 Neumann, 1988, Increase in myocardial G proteins in heart failure, Lancet, 2, 936, 10.1016/S0140-6736(88)92601-3 Bristow, 1992, Beta adrenergic neuroeffector abnormalities in the failing human heart are produced by local, rather than systemic mechanisms, J Clin Invest, 89, 803, 10.1172/JCI115659 Vago, 1989, Identification of alpha-1 adrenergic receptors on sarcolemma from normal subjects and patients with idiopathic dilated cardiomyopathy: characteristics and linkage to GTP-binding protein, Circ Res, 64, 474, 10.1161/01.RES.64.3.474 Ostman-Smith, 1981, Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy, Clin Sci, 1, 265, 10.1042/cs0610265 Fowler, 1986, Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: Progressive receptor downregulation and subsensitivity to agonist response, Circulation, 74, 1290, 10.1161/01.CIR.74.6.1290 Port, 1990, Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart, Circulation, 81, 929, 10.1161/01.CIR.81.3.929 White, 1995, Role of beta adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy, Am J Cardiol, 76, 1271, 10.1016/S0002-9149(99)80355-5 Gilbert, 1993, Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart, Circulation, 88, 472, 10.1161/01.CIR.88.2.472 Gilbert, 1996, Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart, Circulation, 94, 2817, 10.1161/01.CIR.94.11.2817 Bristow, 1995, Improvement in cardiac myocyte function by biological effects of medical therapy: a new concept in the treatment of heart failure, Eur Heart J, 16, 20, 10.1093/eurheartj/16.suppl_F.20 Waagstein, 1975, Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy, Br Heart J, 37, 1022, 10.1136/hrt.37.10.1022 Englemeier, 1985, Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy; a double blind, randomized, placebo controlled trial, Circulation, 72, 536, 10.1161/01.CIR.72.3.536 Gilbert, 1990, Long-term beta blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy, Am J Med, 88, 223, 10.1016/0002-9343(90)90146-5 Woosley, 1980, Suppression of chronic ventricular arrythmias with propranolol, Circulation, 60, 819, 10.1161/01.CIR.60.4.819 Ryden, 1983, A double blind trial of metoprolol in acute myocardial infarction: effects on vertricular arrythmias, N Engl J Med, 308, 614, 10.1056/NEJM198303173081102 Waagstein, 1993, Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy, Lancet, 342, 1441, 10.1016/0140-6736(93)92930-R CIBIS Investigators and Committees, 1994, A randomized trial of beta blockers in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS), Circulation, 90, 1765, 10.1161/01.CIR.90.4.1765 Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101 1997, Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease, Lancet, 349, 375, 10.1016/S0140-6736(97)80008-6 The BEST Steering Committee, 1995, Design of the Betablocker Evaluation Survival Trial (BEST), Am J Cardiol, 75, 1220, 10.1016/S0002-9149(99)80766-8 The CIBIS II Scientific Committee, 1997, Design of the Cardiac Insufficiency Bisoprolol Study II (CIBIS II), Fundam Clin Pharmacol, 11, 138, 10.1111/j.1472-8206.1997.tb00181.x Packer, 1997, A multicenter randomized, double-blind, placebo-controlled study to determine the effect of mortality over 6–46 months in patients with severe congestive heart failure, 158